Pharmaceutical

GRIT and Quangang announce IL-2 T-cell therapy partnership

GRIT has formed a strategic partnership with Quangang Pharmaceutical (Quangang) to enhance research for solid tumour patients in China.

Jun 4, 2024 - 04:00
GRIT and Quangang announce IL-2 T-cell therapy partnership
GRIT has formed a strategic partnership with Quangang Pharmaceutical (Quangang) to enhance research for solid tumour patients in China.
Read the original article

Tags:

Previous Article

Lilly strikes deal with QurAlis for preclinical ALS candidate

Next Article

CHMP approves backing for first acanthamoeba keratitis treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Monoblock Mastery: Capmatic's Innovative Approach to Integrated Packaging Systems

Monoblock Mastery: Capmatic's Innovative Approach to In...

Aug 29, 2023

NICE recommends Rhythm’s Imcivree for rare genetic obesity disorder

NICE recommends Rhythm’s Imcivree for rare genetic obes...

May 23, 2024

Lyme disease cases rise, but largely due to a change in data collection

Lyme disease cases rise, but largely due to a change in...

Feb 15, 2024